N
Novus Diagnostics
Biotech & Life Sciences · Dublin, Ireland · Founded 2020
Developing ground-breaking diagnostics technologies that provide rapid answers right at the patient’s bedside MoreLess
When a patient is critically ill, giving their doctor the right information at the right time can mean the difference between life and death. At Novus Diagnostics, we are developing ground-breaking diagnostics technologies to provide rapid answers right at the patient’s bedside.
Our first product, SepTec, will help tackle the global challenge of sepsis which kills more than 11 million people every year. Our technology platform brings together novel electrochemical sensors, centrifugal microfluidics and automated sample processing and analysis to diagnose and characterise a blood stream infection within 15 minutes; enabling earlier lifesaving targeted treatment. We are a young, driven company working to solve a major global health challenge. We are building a team of people who are excited by this challenge and committed to making a real difference through their work.
Talent graph
Novus Diagnostics's talent
Source: Dealroom Talent Intelligence.
Investors
6 investors on Novus Diagnostics's cap table
Sourced from Dealroom's funding and investor records.






Global footprint
Where Novus Diagnostics has talent and traffic
team presence
Market sentiment
What the market is saying about Novus Diagnostics
An AI-synthesized read of the highest-engagement posts about Novus Diagnostics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Novus Diagnostics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.